Table 1.
Clinical parameters | Cases | Expression level | P-value | |
---|---|---|---|---|
(n) | KAT6Ahigh (n = 53) | KAT6Alow (n = 53) | (*p < 0.05) | |
Age(years) | ||||
<60 years | 64 | 29 | 35 | 0.233 |
≥60 years | 42 | 24 | 18 | |
Gender | ||||
Male | 81 | 42 | 39 | 0.492 |
Female | 25 | 11 | 14 | |
Tumour size (cm) | 0.002* | |||
<5 cm | 58 | 21 | 37 | |
≥5 cm | 48 | 32 | 16 | |
Tumour number | 0.403 | |||
Solitary | 91 | 44 | 47 | |
Multiple | 15 | 9 | 6 | |
Edmondson | 0.020* | |||
I + II | 24 | 7 | 17 | |
III + IV | 82 | 46 | 36 | |
TNM stage | 0.034* | |||
I + II | 83 | 37 | 46 | |
III + IV | 23 | 16 | 7 | |
Venous infiltration | 0.296 | |||
Present | 9 | 6 | 3 | |
Absent | 97 | 47 | 50 | |
AFP | 0.353 | |||
<400 ng/ml | 24 | 14 | 10 | |
≥400 ng/ml | 82 | 39 | 43 | |
HBsAg | 0.727 | |||
Positive | 97 | 48 | 49 | |
Negative | 9 | 5 | 4 |
HCC hepatocellular carcinoma, AFP alpha-fetoprotein, TNM tumour-node-metastasis.
*Bold indicates statistically significant.